First Republic Investment Management, Inc. Aerie Pharmaceuticals Inc Transaction History

First Republic Investment Management, Inc.

$34.7 Billion
Q3 2023

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 03, 2022	SELL	$6.37 - $15.23 $7,752 - $18,534	-1,217 Reduced 6.13%	18,628 $282,000
Q2 2022 Aug 16, 2022	SELL	$4.95 - $9.16 $2,960 - $5,477	-598 Reduced 2.93%	19,845 $149,000
Q1 2022 May 16, 2022	BUY	$5.64 - $9.8 $9,830 - $17,081	1,743 Added 9.32%	20,443 $186,000
Q4 2021 Feb 09, 2022	SELL	$7.02 - $13.33 $4,464 - $8,477	-636 Reduced 3.29%	18,700 $131,000
Q3 2021 Nov 12, 2021	BUY	$11.32 - $16.63 $39,416 - $57,905	3,482 Added 21.96%	19,336 $220,000

Q2 2021 Aug 16, 2021	SELL	$15.16 - $18.97 $2,713 - $3,395	-179 Reduced 1.12%	15,854 $254,000
Q1 2021 May 14, 2021	SELL	$13.12 - $20.9 $10,404 - $16,573	-793 Reduced 4.71%	16,033 $287,000
Q4 2020 Feb 16, 2021	SELL	$9.12 - $14.49 $49,065 - $77,956	-5,380 Reduced 24.23%	16,826 $227,000
Q3 2020 Nov 12, 2020	SELL	$10.46 - $14.46 $8,556 - $11,828	-818 Reduced 3.55%	22,206 $261,000
Q2 2020 Aug 13, 2020	BUY	$12.0 - $16.13 $1,500 - $2,016	125 Added 0.55%	23,024 $340,000
Q1 2020 May 13, 2020	BUY	$11.84 - $25.52 $62,917 - $135,613	5,314 Added 30.22%	22,899 $309,000
Q4 2019 Feb 14, 2020	BUY	$17.72 - $25.1 $121,541 - $172,160	6,859 Added 63.95%	17,585 $425,000
Q3 2019 Nov 08, 2019	BUY	$18.41 - $28.0 $197,465 - $300,328	10,726 New	10,726 $206,000
Q2 2019 Aug 07, 2019	SELL	$28.97 - $48.21 $140,678 - $234,107	-4,856 Closed	0 $0
Q1 2019 Apr 30, 2019	SELL	$36.32 - $49.25 $45,726 - $62,005	-1,259 Reduced 20.59%	4,856 $231,000
Q4 2018 Feb 12, 2019	BUY	$33.0 - $60.04 $57,420 - $104,469	1,740 Added 39.77%	6,115 $221,000
Q3 2018 Nov 13, 2018	BUY	$56.15 - $73.9 $16,171 - $21,283	288 Added 7.05%	4,375 $269,000
Q2 2018 Aug 14, 2018	BUY	$47.85 - $70.45 $195,562 - $287,929	4,087 New	4,087 $276,000

Others Institutions Holding AERI

# of Institutions

Shares Held

2.4M

Call Options Held

Put Options Held

View Full List

About AERIE PHARMACEUTICALS INC

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

More about AERI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Republic Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Republic Investment Management, Inc. with notifications on news.

Account